YOLFTbeta
Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

LXRX · NASDAQ · Healthcare / Biotechnology

1.79USD-0.03 (-1.65%)

Price History

Full chart

Market Stats

Previous Close1.82
Open1.83
Day Range1.72 – 1.83
52-Week Range1.10 – 2.68
Volume1.89M
Market Cap798.70M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.16
Dividend Yield0.00%
Beta1.03
50-Day Avg2.25
200-Day Avg1.83

About

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Michael S. Exton Ph.D.
  • Employees81
  • Headquarters2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381, USA
  • Websitehttps://www.lexpharma.com

Leadership

  • Dr. Michael S. Exton Ph.D.CEO & Director · b. 1970
  • Mr. Scott M. CoianteSenior VP & CFO · b. 1967
  • Mr. Brian T. CrumSenior VP, General Counsel & Secretary · b. 1973
  • Ms. Wendy E. McDermottSenior Vice President of Human Resources · b. 1971
  • Dr. Craig B. Granowitz M.D., Ph.D.Senior VP & Chief Medical Officer · b. 1965
  • Ms. Kristen L. AlexanderVice President of Finance & Accounting · b. 1968
  • Ms. Lisa M. DeFrancescoSenior Vice President of Investor Relations & Corporate Communications · b. 1980
  • Dr. Suma Gopinathan M.S., Ph.D.Senior Vice President of Discovery · b. 1973

Financials

Income Statement

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.70M14.46M305.58M35.20M42.84M61.74M75.68M72.80M50.12M32.32M10.70M4.91M1.85M1.09M2.22M22.85M130.01M83.34M90.33M63.21M322.07M24.00M298.00K139.00K1.20M31.08M49.80M
Growth (%)-+207.63%+2013.47%-88.48%+21.70%+44.12%+22.58%-3.81%-31.15%-35.51%-66.89%-54.13%-62.33%-41.10%+104.04%+928.53%+468.89%-35.90%+8.40%-30.03%+409.54%-92.55%-98.76%-53.36%+766.19%+2481.48%+60.24%
Cost of Revenue-2.00M-2.62M68.44M87.78M94.02M97.16M100.14M116.83M115.81M120.93M94.50M91.62M103.49M82.57M89.68M89.28M95.19M163.97M1.90M2.49M3.23M1.93M55.05M52.52M58.97M616.00K274.00K
Gross Profit6.70M17.08M305.58M35.20M42.84M61.74M75.68M72.80M50.12M32.32M10.70M4.91M1.85M-81.48M-87.46M-66.42M34.83M-80.64M88.44M60.72M318.84M22.07M-54.75M-52.38M-57.77M30.46M49.53M
Gross Margin142.55%118.13%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-7482.55%-3936.09%-290.65%26.79%-96.76%97.90%96.06%99.00%91.96%-18371.81%-37681.29%-4798.01%98.02%99.45%
Operating Expense19.50M52.56M349.22M98.09M105.43M109.19M111.80M128.03M125.07M128.86M100.66M100.63M115.94M26.93M14.91M33.94M33.36M56.52M225.12M164.00M177.40M69.87M32.34M48.38M113.98M227.58M98.44M
Operating Income-12.80M-35.48M-43.64M-62.89M-62.59M-47.45M-36.12M-55.23M-74.95M-96.53M-89.96M-95.72M-114.09M-108.42M-102.37M-100.37M1.47M-137.16M-136.68M-103.28M141.44M-47.80M-87.09M-100.76M-171.75M-197.12M-48.91M
Operating Margin-272.34%-245.37%-14.28%-178.67%-146.12%-76.86%-47.73%-75.87%-149.56%-298.68%-840.71%-1950.24%-6170.63%-9955.46%-4607.16%-439.16%1.13%-164.58%-151.30%-163.39%43.92%-199.21%-29224.83%-72489.21%-14264.95%-634.20%-98.21%
EBITDA-10.80M-32.86M-27.09M-42.31M-41.06M-34.58M-24.48M-39.98M-64.53M-86.26M-84.29M-93.69M-108.80M-103.91M-99.29M-96.18M11.72M-125.82M-125.27M-96.09M148.45M-41.10M-86.66M-100.03M-169.76M-184.29M-41.38M
EBITDA Margin-229.79%-227.24%-8.86%-120.21%-95.86%-56.01%-32.35%-54.91%-128.76%-266.90%-787.79%-1908.88%-5884.26%-9541.51%-4468.59%-420.86%9.01%-150.97%-138.67%-152.02%46.09%-171.27%-29081.88%-71966.19%-14099.34%-592.93%-83.09%
Net Income-12.50M-25.99M-35.17M-59.67M-64.20M-47.17M-36.31M-54.31M-58.79M-76.86M-82.78M-101.78M-116.22M-110.21M-104.13M-100.29M-4.68M-141.43M-129.05M-120.55M130.13M-58.57M-87.76M-101.94M-177.12M-200.40M-50.34M
Net Income Margin-265.96%-179.78%-11.51%-169.52%-149.86%-76.40%-47.98%-74.61%-117.31%-237.80%-773.64%-2073.66%-6285.29%-10120.39%-4686.14%-438.85%-3.60%-169.71%-142.86%-190.71%40.40%-244.11%-29448.99%-73341.01%-14710.88%-644.78%-101.08%
R&D14.60M31.65M53.35M74.86M82.20M90.59M93.63M106.69M104.33M108.58M81.24M75.35M91.83M82.57M89.68M89.28M95.19M178.15M156.81M100.24M91.92M153.62M55.05M52.82M58.89M84.48M61.12M
R&D as % of Total Revenue310.64%218.88%17.46%212.67%191.88%146.72%123.71%146.56%208.17%335.93%759.23%1535.25%4966.36%7582.55%4036.09%390.65%73.21%213.77%173.59%158.59%28.54%640.22%18471.81%37997.12%4890.95%271.81%122.73%
Interest Expense0422.04K314.00K7.00K325.00K2.66M3.28M3.25M2.77M2.69M2.97M2.72M2.53M2.11M1.97M2.25M6.72M6.57M6.98M20.78M20.68M14.54M802.00K2.78M13.10M15.58M8.34M
Interest Expense % of Total Revenue0.00%2.92%0.10%0.02%0.76%4.31%4.33%4.47%5.53%8.33%27.72%55.40%136.72%194.12%88.70%9.86%5.17%7.88%7.73%32.87%6.42%60.61%269.13%2000.00%1088.12%50.12%16.74%

Balance Sheet

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets22.30M220.69M239.99M201.77M284.20M211.98M218.71M190.27M369.30M261.51M257.76M366.88M430.51M371.78M274.16M471.38M654.83M475.63M436.54M284.14M417.71M203.79M136.91M194.30M229.43M298.42M184.99M
Total Liabilities14.10M13.06M21.62M31.87M117.98M90.39M132.91M104.77M82.72M65.68M94.26M119.86M132.94M105.10M104.00M187.36M368.98M318.22M384.44M310.54M300.61M47.42M23.31M77.17M136.32M152.47M77.45M
Total Equity8.20M207.63M218.37M169.90M166.22M121.59M85.80M85.50M256.30M185.58M163.79M247.02M297.57M266.68M-1.00B284.02M285.85M157.40M52.10M-1.47B117.10M156.37M113.59M117.12M93.11M145.95M107.54M
Cash2.00M37.81M23.05M39.36M81.92M14.61M21.97M30.23M22.94M85.87M100.55M47.21M281.69M223.21M129.13M339.34M521.35M346.50M310.79M160.05M36.11M126.26M64.06M46.34M22.46M66.66M34.33M
Total Debt13.00M2.85M-4.00M56.34M37.63M36.94M32.19M31.37M30.49M66.96M28.48M48.34M23.45M21.88M107.67M105.81M101.45M245.67M245.00M246.84M12.81M2.28M55.29M106.06M108.40M62.24M
Net Debt11.00M-34.96M-23.05M-35.36M-25.57M23.02M14.97M1.96M8.44M-55.38M-33.59M-18.73M-256.80M-199.76M-107.25M-231.67M-415.54M-245.06M-65.12M84.95M210.73M-113.45M-61.79M8.95M83.60M41.74M27.91M

Cash Flow

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-9.60M-1.50M-17.99M-28.79M-7.72M-42.26M23.44M-56.91M-74.32M-95.60M-89.02M-82.37M-87.94M-94.46M-91.08M-75.62M184.78M-175.63M-185.39M-148.61M113.81M-142.97M-87.02M-88.85M-161.90M-178.78M-67.85M
Investing Cash Flow5.20M-165.45M6.42M47.23M-128.00K40.48M-15.99M24.46M-187.95M159.41M11.88M-113.84M69.95M-97.81M99.54M-108.42M-117.02M18.25M50.52M169.58M-155.85M380.76M2.11M-71.08M-49.94M-15.38M113.02M
Financing Cash Flow3.40M202.73M-3.19M4.57M50.40M-19.47M-95.00K40.70M254.99M-880.00K91.82M142.87M157.08M36.38M-1.39M283.81M-2.03M987.00K149.93M-2.24M-2.23M-147.64M22.71M142.21M187.96M238.35M-48.50M
Capital Expenditure4.10M7.71M13.47M19.77M4.82M11.81M11.28M3.58M1.90M2.19M369.00K1.13M1.21M492.00K1.72M80.00K910.00K231.00K228.00K95.00K70.00K87.00K1.22M1.33M470.00K1.03M0
Free Cash Flow-13.70M-9.21M-31.46M-48.56M-12.54M-54.07M12.16M-60.49M-76.22M-97.79M-89.39M-83.50M-89.14M-94.95M-92.80M-75.70M183.87M-175.86M-185.62M-148.70M113.74M-143.06M-88.24M-90.18M-162.37M-179.81M-67.85M
Dividends Paid------------3.59M1.44M0002.02M0--216.58M11.70M-99.92M--
FCF to OCF142.71%613.46%174.88%168.65%162.52%127.95%51.88%106.29%102.56%102.29%100.41%101.37%101.37%100.52%101.89%100.11%99.51%100.13%100.12%100.06%99.94%100.06%101.40%101.49%100.29%100.58%100.00%
Dividend Paid to FCF-------------4.03%-1.52%0.00%0.00%0.00%-1.15%0.00%---151.40%-13.26%--61.54%--

Earnings

Report DateJul 27, 2000Oct 26, 2000Mar 7, 2001May 8, 2001Aug 7, 2001Nov 6, 2001Mar 7, 2002May 9, 2002Aug 7, 2002Oct 30, 2002Feb 19, 2003May 1, 2003Jul 31, 2003Oct 30, 2003Feb 19, 2004Apr 29, 2004Jul 29, 2004Oct 28, 2004Feb 24, 2005Apr 28, 2005Jul 28, 2005Nov 1, 2005Feb 22, 2006May 2, 2006Aug 1, 2006Oct 31, 2006Feb 21, 2007May 1, 2007Jul 31, 2007Oct 30, 2007Mar 6, 2008Apr 29, 2008Jul 29, 2008Oct 30, 2008Feb 25, 2009Apr 28, 2009Jul 28, 2009Oct 27, 2009Feb 23, 2010May 10, 2010Aug 9, 2010Nov 5, 2010Feb 24, 2011May 3, 2011Aug 8, 2011Nov 1, 2011Feb 22, 2012May 3, 2012Jul 31, 2012Nov 6, 2012Feb 21, 2013May 10, 2013Jul 30, 2013Nov 12, 2013Feb 28, 2014May 8, 2014Aug 7, 2014Nov 4, 2014Mar 4, 2015Apr 29, 2015Aug 7, 2015Nov 6, 2015Mar 1, 2016May 3, 2016Aug 4, 2016Nov 1, 2016Mar 3, 2017May 2, 2017Aug 1, 2017Nov 8, 2017Feb 22, 2018May 3, 2018Jul 30, 2018Nov 1, 2018Mar 13, 2019May 1, 2019Jul 31, 2019Nov 7, 2019Mar 12, 2020Apr 27, 2020Jul 29, 2020Oct 29, 2020Mar 10, 2021May 6, 2021Jul 30, 2021Nov 3, 2021Feb 28, 2022May 5, 2022Aug 2, 2022Nov 9, 2022Mar 2, 2023May 2, 2023Aug 3, 2023Nov 8, 2023Mar 11, 2024May 2, 2024Aug 1, 2024Nov 12, 2024Mar 10, 2025May 13, 2025Aug 6, 2025Nov 6, 2025Mar 5, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate-0.44-0.70-0.87-1.05-0.98-1.04-1.26-1.96-1.78-1.80-2.05-2.12-2.13-2.12-1.43-1.78-1.95-1.74-0.78-1.96-2.04-1.820.26-1.24-1.94-1.71-1.66-2.01-1.54-1.11-0.87-1.00-1.12-1.12-1.19-0.98-1.19--0.98-0.49-0.56-0.56-0.56-0.47-0.56-0.57-0.58-0.42-0.40-0.37-0.35-0.35-0.38-0.38-0.38-0.35-0.34-0.34-0.21-0.37-0.35-0.54-0.38-0.25-0.40-0.49-0.51-0.42-0.43-0.37-0.41-0.44-0.37-0.35-0.29-0.24-0.091.30-0.92-0.81-0.72-0.12-0.28-0.21-0.20-0.18-0.18-0.17-0.16-0.14-0.13-0.16-0.16-0.22-0.23-0.20-0.19-0.17-0.12-0.10-0.08-0.07-0.07-0.04-0.06-0.05
EPS Actual-0.56-0.21-0.77-0.77-1.05-0.49-1.12-1.54-1.68-1.89-1.54-1.96-2.03-1.40-1.33-1.75-1.82-1.61-0.07-1.47-1.61-1.540.63-1.19-1.82-1.40-1.33-1.68-1.54-0.98-0.63-0.91-1.05-1.05-0.77-1.12-1.05-0.98-0.91-0.91-0.52-0.56-0.49-0.63-0.51-0.56-0.70-0.42-0.35-0.28-0.35-0.34-0.39-0.41-0.21-0.40-0.35-0.39-0.04-0.28-0.27-0.280.76-0.34-0.37-0.35-0.31-0.33-0.33-0.29-0.31-0.40-0.33-0.26-0.16-0.21-0.222.18-0.48-0.63-0.63-0.42-0.04-0.15-0.13-0.16-0.17-0.16-0.16-0.13-0.16-0.17-0.22-0.21-0.20-0.20-0.17-0.18-0.09-0.070.01-0.04-0.04-0.00-0.06-
Surprise-27.27%70.00%11.49%26.67%-7.14%52.88%11.11%21.43%5.62%-5.00%24.88%7.55%4.69%33.96%6.99%1.69%6.67%7.47%91.03%25.00%21.08%15.38%142.31%4.03%6.19%18.13%19.88%16.42%0.00%11.71%27.59%9.00%6.25%6.25%35.29%-14.29%11.76%-7.14%-85.71%7.14%0.00%12.50%-34.04%8.93%1.75%-20.69%0.00%12.50%24.32%0.00%2.86%-2.63%-7.89%44.74%-14.29%-2.94%-14.71%80.95%24.32%22.86%48.15%300.00%-36.00%7.50%28.57%39.22%21.43%23.26%21.62%24.39%9.09%10.81%25.71%44.83%12.50%-144.44%67.69%47.83%22.22%12.50%-250.00%85.71%28.57%35.00%11.11%5.56%5.88%0.00%7.14%-23.08%-6.25%-37.50%4.55%13.04%0.00%10.53%-5.88%27.88%30.00%112.50%42.86%40.30%93.50%0.00%-
Timing----Pre-marketPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hours-After-hoursPre-marketPre-market-Pre-marketPre-market--Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap798.70M
Enterprise Value783.05M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio-0.14
Price / Sales19.26
Price / Book5.24
EPS-0.16
Book Value0.392
Revenue (TTM)41.47M
Gross Profit (TTM)35.67M
EBITDA-54.02M
Profit Margin-147.38%
Operating Margin-3835.26%
Return on Equity-40.21%
Return on Assets-14.32%
Shares Outstanding444.96M
Shares Float218.99M
Beta1.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 5 analystsTarget 3.86
  • Strong Buy
    1
  • Buy
    2
  • Hold
    2

Ownership Breakdown

Institutions
83.80%
Insiders
1.12%
Retail / Other
15.08%

Top Institutional Holders

  • Artal Group S A
    175.16M39.36%
  • FMR Inc
    45.06M10.13%
  • Siren, L.L.C.
    44.30M9.96%
  • Sessa Capital, L.P
    17.91M4.03%
  • Vanguard Capital Management, LLC
    9.52M2.14%
  • Point72 Asset Management, L.P.
    7.81M1.76%
  • BlackRock Inc
    3.32M0.75%
  • Geode Capital Management, LLC
    3.17M0.71%
  • Jane Street Group LLC
    2.67M0.60%
  • UBS Group AG
    2.48M0.56%
  • Marshall Wace Asset Management Ltd
    2.38M0.53%
  • Susquehanna International Group, LLP
    2.12M0.48%

Top Fund Holders

  • Fidelity Growth Company Fund
    19.05M4.29%
  • Vanguard MStar Total Stk Mkt Idx Invest
    7.08M1.59%
  • iShares Russell 2000 ETF
    6.23M1.40%
  • Fidelity Growth Company K6
    5.60M1.26%
  • Fidelity Series Growth Company
    4.56M1.03%
  • Fidelity Select Biotechnology
    4.06M0.91%
  • Fidelity Small Cap Index
    2.70M0.61%
  • iShares Russell 2000 Growth ETF
    2.30M0.52%

Stock Splits

  • May 21, 20151:7